In recent years, Glasgow has been gaining prominence as a hub for innovation and entrepreneurship.
From technology to healthcare, young companies are harnessing creativity and drive to disrupt industries and accelerate economic growth in the region.
Recently, Glasgow City Council, in collaboration with Dealroom, announced the Top 50 Startups in the Glasgow City Region list.
Glasgow City Region’s tech ecosystem platform partner Dealroom uses data-driven insights to rank startups through its Dealroom Signal algorithm, which highlights promising companies based on various indicators such as growth, hiring trends, fundraising timelines, and team composition.
The list shows a combined enterprise value of £1.3B, a 4.9x growth in value since 2020 with top sectors including health, energy, and enterprise software.
Having said that, these startups are not only attracting attention for their innovations and services but also creating job opportunities for those looking to be part of something impactful.
Whether you are a recent graduate, a seasoned professional, or someone looking to make a
career transition, these startups offer a range of positions and growth opportunities.
Chemify
Founder/s: Lee Cronin
Hiring status: Yes| Apply here
Chemify utilises its proprietary technology for molecular design, discovery, and chemical manufacturing to offer improved molecules to pharmaceutical, biotechnology, and industrial partners.
The company can assist in reducing the cost and time required for experimental processes, thus accelerating the development of promising new molecules. This can contribute to advancements in medicine, agriculture, materials science, and green energy.
ENOUGH
Founder/s: NA
Hiring status: Yes| Apply here
Glasgow-based ENOUGH (formerly 3F BIO) is a food tech startup revolutionising protein production by fermenting fungi with renewable feedstocks.
The company claims that its flagship product, ABUNDA mycoprotein, is a sustainable source of food protein suitable for various diets, including vegan, vegetarian, or flexitarian.
Supported by the Bio-Based Industries Joint Undertaking within the European Union’s Horizon 2020 program, ENOUGH is constructing a protein factory to initially produce 10,000 tonnes per annum, with plans to scale production significantly by 2032.
Causeway Therapeutics
CEO: Dr Derek Gilchrist
Hiring status: No
Causeway Therapeutics is a clinical-stage biopharmaceutical company specialising in musculoskeletal health. It develops novel microRNA therapies for the treatment of common musculoskeletal and age-related diseases.
Mironid
CEO: Dr Neil Wilkie
Hiring status: No
Mironid is a biopharmaceutical company developing small molecule therapeutics for the treatment of life-threatening hereditary kidney disease.
Its lead programme is for Autosomal Dominant Polycystic Kidney Disease (ADPKD), which is characterised by uncontrolled growth of fluid-filled cysts and is the most common hereditary kidney disorder, but has limited treatment options.
The company’s first-in-class small molecule LoAc drug candidates directly target the abnormally high kidney cAMP levels that drive cyst formation.
Staff Scanner
Founder/s:Reza Najafian
Hiring status: No
Staffscanner is an application tailored for the healthcare industry that connects carers and nurses of all levels with care providers, offering, convenience, and financial benefits for all parties involved.
Unlike traditional recruitment agencies, Staffscanner eliminates the middleman and high agency fees, providing control and access to trusted, vetted staff for shifts.
The app allows care providers to preview carers’ profiles, ensuring the assembly of the most suitable and reliable team for a productive workday.
Glox Therapeutics
CEO: Dr. James Clark
Hiring status: No
Glox Therapeutics is developing precision antibiotics using engineered protein bacteriocins. These antimicrobials target Gram-negative pathogens, including antibiotic-resistant strains like Pseudomonas aeruginosa and Klebsiella pneumoniae.
Bacteriocins, naturally produced by bacteria, offer targeted antimicrobial properties. Glox Therapeutics aims to advance antimicrobial therapy by leveraging bacteriocins to selectively eliminate pathogens while preserving patient microbiomes.
Nami Surgical
Founder/s: Nico Fenu and Dr. Rebecca Cleary
Hiring status: No
Nami Surgical develops miniaturised ultrasonic medical devices for surgical applications and supports medical device companies to deliver innovation in ultrasonic surgery.
The Scottish company has introduced a high-performance, miniaturised ultrasonic scalpel, overcoming significant barriers in robotic-assisted surgery.
Phlo
Founder/s: Nadeem Sarwar
Hiring status: Yes| Apply here
Phlo started as a digital pharmacy platform and has evolved into a comprehensive healthcare solution provider.
In addition to pharmacy services, Phlo offers Phlo Connect, a digital infrastructure platform, Phlo Clinic for on-demand clinician access, and specialised healthcare services with Hello Eve tailored for women’s healthcare needs.
Go Swag
Founder/s: Ben Greenock and Conor McKenna
Hiring: No
Go Swag specialises in providing branded gifts and promotional items for businesses of all sizes. The company creates personalised welcome packs for employees and offers branded giveaways for events.
Go Swag’s business model covers all aspects of branded gift creation and distribution, generating revenue by charging businesses for these services.
Utopi
Founder/s: Jonathan Burridge
Hiring status: Yes| Apply here
Utopi specialises in simplifying data acquisition and ESG reporting to support decarbonisation efforts within the multi-tenant real estate sector.
By bridging the gap between Proptech and Climate tech, the Glasgow-based company provides solutions aimed at addressing the climate problem within real estate portfolios.
Using cost-effective IoT technology, the company collects, analyses, and reports real-time ESG data, engaging resident communities to encourage action against the climate crisis.
01
Empowering digital transformation: How Sigli combines values, AI, and tech to drive change